Cortisol Excess: Clinical Trials

7 trials for Cortisol Excess, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 recruiting, 1 active not recruiting, 1 completed. 2 Not applicable, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable2Active not recruiting 1, Unknown 1
Phase 22Completed 1, Recruiting 1

Follow Cortisol Excess: new trials by email Literature Review of Cortisol Excess trials Research Report on Cortisol Excess

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
EndoSense: Continuous Real-Time Monitoring of Health Markers in Endocrine and Metabolic Disorders
Sequential Dietary Sodium Modulation - Endocrine Disorders, Hypertension
Not applicableActive not recruitingFelix Beuschlein1002026-07-032026-07-27
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
clofutriben, Placebo - Type 2 Diabetes, Cortisol Excess
Phase 2RecruitingSparrow Pharmaceuticals15002025-11-292026-10-06
Cerebrovascular Disease: Quality of Life (CODE: QoL)
questionnaire, hair samples, blood samples, clinical exam - Quality of Life, Stroke, Acute
RecruitingUniversity of Zurich6802023-05-272024-06-05
PATHophysiology of OSteoporosis: Role of Hidden Cortisol Excess and Its Predictors in Bone Fragility
Osteoporosis, Bone Fracture
UnknownIstituto Auxologico Italiano15002023-04-242024-03-21
Effects of "Vitamin N" Nature Immersion Therapy on Stress Levels in Health Care Workers in the City of Bogotá
Immersion therapy in nature - Vitamin N - Cortisol Excess, Stress, Psychological
Not applicableUnknownJeadran N. Malagón-Rojas1182022-10-152024-09-27
SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome
SPI-62, Placebo - Cushing's Syndrome I, Cushing Disease Due to Increased ACTH Secretion
Phase 2CompletedSparrow Pharmaceuticals262022-09-012025-10-08
Prevalence of Hidden Hypercortisolism in Osteoporosis
Osteoporosis, Cortisol Excess
UnknownIstituto Auxologico Italiano10002022-05-262023-03-09

Narrower conditions

ACTH Syndrome, Ectopic (7)  ·  Cushing Syndrome (2)  ·  Osteoporosis (2)  ·  Anxiety Disorders (1)  ·  Caregiver Burden (1)  ·  Cerebral Hemorrhage (1)  ·  Cerebrovascular Disorders (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Endocrine System Diseases (1)  ·  Fractures, Bone (1)  ·  Hyperaldosteronism (1)  ·  Hypertension (1)  ·  Ischemic Attack, Transient (1)  ·  Obesity (1)  ·  Overweight (1)

Broader conditions

Neoplasms (7)  ·  Paraneoplastic Endocrine Syndromes (7)  ·  Paraneoplastic Syndromes (7)  ·  Nutritional and Metabolic Diseases (4)  ·  Adrenal Gland Diseases (3)  ·  Adrenocortical Hyperfunction (3)  ·  Metabolic Diseases (3)  ·  Behavior (2)  ·  Behavioral Symptoms (2)  ·  Bone Diseases (2)  ·  Bone Diseases, Metabolic (2)  ·  Brain Diseases (2)  ·  Cardiovascular Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Endocrine System Diseases (2)

Interventions

ASP3662 (1)  ·  Blood Specimen Collection (1)  ·  Forest Therapy (1)

Sponsors

Istituto Auxologico Italiano (2)  ·  Sparrow Pharmaceuticals (2)  ·  Felix Beuschlein (1)  ·  Jeadran N. Malagón-Rojas (1)  ·  University of Zurich (1)

Countries

Italy (2)  ·  Switzerland (2)  ·  United States (2)  ·  Bulgaria (1)  ·  Colombia (1)  ·  Romania (1)

Top investigators

Elisa Cairoli, MD (1)  ·  Felix Beuschlein, Prof. Dr. med. (1)  ·  Frank Czerwiec, MD (1)  ·  Iacopo Chiodini, Professor (1)  ·  Susanne Wegener, MD (1)  ·  Thomas Uslar, MD; Assistant Professor (1)

NIH funding

2023 (1), 2025 (1)